8-th General Assembly

28.11.2019

 

The NoCanTher Consortium has gathered for the 8th General Assembly in London (UK), at the premises of the Royal Institution. At this meeting, researchers discussed the project's progress and defined the next steps for the oncoming months. 

The NoCanTher consortium is composed of eleven partners from different areas of expertise. NoCanTher aims at translating nanoformulations based on magnetic iron oxide nanoparticles to early clinical development for pancreatic cancer.